NCT03046121

Brief Summary

This study will address the effectiveness of Family-centered Function Focused Care (Fam-FFC). Fam-FFC is a theoretically-based approach to care in which family caregivers partner with nurses to prevent functional decline and other complications related to hospitalization in older adults with Alzheimer's disease and related dementias. A systematic care pathway promotes information-sharing and decision-making that promotes physical activity, function, and cognitive stimulation during the hospitalization and immediate post-acute period. Our goal in this work is to establish a practical and effective way to optimize function and physical activity; decrease neuropsychiatric symptoms, delirium, and depression; prevent avoidable post-acute care dependency; and prevent unnecessary rehospitalizations and long-stay nursing home admissions, while mitigating family caregiver strain and burden.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
461

participants targeted

Target at P75+ for not_applicable alzheimer-disease

Timeline
Completed

Started Nov 2017

Longer than P75 for not_applicable alzheimer-disease

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 8, 2017

Completed
9 months until next milestone

Study Start

First participant enrolled

November 6, 2017

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 23, 2023

Completed
6 months until next milestone

Results Posted

Study results publicly available

June 6, 2024

Completed
Last Updated

June 6, 2024

Status Verified

May 1, 2024

Enrollment Period

4.3 years

First QC Date

January 30, 2017

Results QC Date

December 28, 2023

Last Update Submit

May 9, 2024

Conditions

Keywords

dementiaacute carepost-acute recoveryfamily caregivers

Outcome Measures

Primary Outcomes (2)

  • Return to Baseline Physical Function Based on the Barthel Index (Change From 2 Weeks Prior to Admission and Changes at Admission, Discharge, and 2 and 6 Months Post-discharge).

    Assessed using the Barthel Index, comparing the change from 2 weeks prior to admission to changes at admission, discharge, and 2 and 6 months post-discharge. Return to baseline physical function (yes/no) was scored as yes if the participant's functional status was the same as baseline, within five points or less than baseline, or greater than baseline. Scores ranged from 0 to 1, with higher scores representing better outcomes.

    Change from 2 weeks prior to admission to changes at admission, discharge, and 2 and 6 months post-discharge

  • Caregiver Preparedness

    Assessed by the Preparedness for Caregiving Scale with scores ranging from 0 to 4 and higher scores indicating greater perceived preparedness.

    Discharge and 2 and 6 months post-discharge

Secondary Outcomes (10)

  • Delirium Severity

    Admission, Discharge, 2 and 6 months post-discharge

  • Behavior

    Admission, Discharge, 2 and 6 months post-discharge

  • Moderate Physical Activity Level

    admission, discharge, 2 and 6 months post-discharge

  • Depression

    admission, discharge, 2 and 6 months post-discharge

  • Caregiver Strain

    Discharge and 2 and 6 months post-discharge

  • +5 more secondary outcomes

Other Outcomes (1)

  • Health Care Cost

    end of intervention at each study site, 12 months after enrollment initiated

Study Arms (2)

Fam-FFC

EXPERIMENTAL

The intervention consists of :Component 1- Environmental and Policy Assessments; Component II- Education of Nursing Staff; Component III-Ongoing Training/Motivation of Nursing Staff. The Fam-FFC Nurse will work with the champions to mentor and motivate nursing staff to provide: (a) role modeling Fam-FFC, reinforcing performance of Fam-FFC, and brainstorming about ways to overcome challenges; (b) highlighting staff role models; Component IV Implementation of the FamPath Pathway which includes: (a) information on the admitting condition, diagnostics, treatment;(b) family/patient education; (c) transitional hand-off to post-acute providers; and (d) post-acute follow-up to provide ongoing education and modification of the function-focused care plan.

Behavioral: Family-centered Function-focused Care (Fam-FFC)

Attention Control (Fam- FFC Ed-only)

NO INTERVENTION

Education of the nursing staff in participating hospital units (exactly as offered in treatment sites), and education of family caregivers about hospital orientation and reinforcement of discharge teaching (medications/treatments, medical follow-up).

Interventions

An educational empowerment model for family CGs that includes a care pathway, provided within a social-ecological in-patient framework promoting specialized care to patients with ADRD. The intervention creates an "enabling" milieu for the person with ADRD through environmental and policy assessment/modification, staff education, unit-based champions, and individualized goal setting that focuses on functional recovery during hospitalization and the immediate post-acute period.

Fam-FFC

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may not qualify if:

  • Staff nurses (at the conclusion of the intervention at each site) who identify the intervention unit as the primary unit worked, and speak English or Spanish, will be included in focus groups
  • For the exploratory aim of assessing the cultural appropriateness of the intervention, we will recruit family caregivers who self-identify as black, Latino, Asian and white, randomly selected from the Fam-FFC sample. Approximately 10 percent of families from each ethnic group represented in the study will be approached for consent for participation in interviews. (If theoretical saturation is not reached, interviews will continue until saturation is reached). Additionally, the six nurse champions will be consented and interviewed after the study ends in his/her particular unit/setting to provide their perspective on the cultural appropriateness of Fam-FFC.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Lancaster General Medical Center

Lancaster, Pennsylvania, 17602, United States

Location

Presbyterian Medical Center

Philadelphia, Pennsylvania, 19104, United States

Location

Chester County Hospital

West Chester, Pennsylvania, 19380, United States

Location

Related Publications (4)

  • Kuzmik A, Best I, Al Harrasi AM, Boltz M. Mediating role of care partner burden among dementia care partners during post-hospital transition. Aging Ment Health. 2024 Dec;28(12):1753-1759. doi: 10.1080/13607863.2024.2370441. Epub 2024 Jun 25.

  • Kuzmik A, BeLue R, Resnick B, Rodriguez M, Berish D, Galvin JE, Boltz M. Caregiver preparedness is associated with desire to seek long-term care admission of hospitalized persons with dementia. Int J Geriatr Psychiatry. 2023 Sep;38(9):e6006. doi: 10.1002/gps.6006.

  • Paudel A, Ann Mogle J, Kuzmik A, Resnick B, BeLue R, Galik E, Liu W, Behrens L, Jao YL, Boltz M. Gender differences in interactions and depressive symptoms among hospitalized older patients living with dementia. J Women Aging. 2023 Sep-Oct;35(5):476-486. doi: 10.1080/08952841.2022.2146972. Epub 2022 Nov 26.

  • Boltz M, Kuzmik A, Resnick B, Trotta R, Mogle J, BeLue R, Leslie D, Galvin JE. Reducing disability via a family centered intervention for acutely ill persons with Alzheimer's disease and related dementias: protocol of a cluster-randomized controlled trial (Fam-FFC study). Trials. 2018 Sep 17;19(1):496. doi: 10.1186/s13063-018-2875-1.

MeSH Terms

Conditions

Alzheimer DiseaseDementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Limitations and Caveats

The study was limited by geographic location and attrition due to deaths which is common in this population.

Results Point of Contact

Title
Marie Boltz PhD
Organization
Penn State University

Study Officials

  • Marie Boltz, PhD

    Penn State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 30, 2017

First Posted

February 8, 2017

Study Start

November 6, 2017

Primary Completion

February 28, 2022

Study Completion

December 23, 2023

Last Updated

June 6, 2024

Results First Posted

June 6, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations